Randomized controlled trial of adjuvant uracil–tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer

Abstract
Survival advantage following adjuvant chemotherapy
Funding Information
  • Japan Health Sciences Foundation
  • Taiho Pharmaceutical Company